目的探讨转染同源盒基因A13(HOXA13)对人血清白蛋白(HSA)诱导的人肾小管上皮细胞(HKC)间充质转化(EMT)和骨形成蛋白7(BMP-7)表达的影响。方法体外培养的HKC细胞株经人血清白蛋白(20 mg/mL)作用48 h后,采用免疫印迹法检测HKC细胞角蛋白(CK)、波形蛋白(vimentin)和HOXA13蛋白的表达。应用脂质体转染技术上调HKC细胞HOXA13表达,观察HOXA13不同表达水平对人血清白蛋白超载诱导CK、vimentin、BMP-7表达改变的影响。结果 20 mg/mL HSA刺激HKC细胞48 h后,HKC细胞出现EMT样改变:CK表达下降(P<0.01)、vimentin表达增高(P<0.01);HSA超载同时使HKC细胞内HOXA13、BMP-7表达下降。HOXA13转染上调HKC细胞内HOXA13表达后,显著抑制了HSA超载诱导的EMT发生(P<0.05)和BMP-7表达的下降(P<0.05)。结论转染HOXA13可拮抗白蛋白超载诱导HKC细胞发生EMT的作用,这种作用可能与HOXA13上调BMP-7表达有关。
Abstract
Objective To examine the transfection of Homeobox A13(HOXA13) on epithelial-mesenchymal transition (EMT) and the expression of bone morphogenetic protein-7(BMP-7) induced by albumin-overload in human kidney tubular epithelial cells (HKCs). Methods The cultured HKCs were treated with 20 mg/mL human serum albumin (HSA) for 48 hours. Protein expression of cytokeratin (CK), vimentin and HOXA13 in the HKCs was assessed by Western blot. Protein expression of CK, vimentin, and BMP-7 was also detected in HKCs transfected with lipofectamine contained HOXA13 DNA. Results HSA induced EMT in HKCs, presented by decreased CK expression (P<0.01) and increased vimentin expression (P<0.01). The up-regulated expression of HOXA13 transfected by lipofectamine inhibited the level of EMT induced by HSA in HKCs (P<0.05). The decreased rate of BMP-7 protein expression induced by HSA was inhibited by over-expressed HOXA13 in HKCs (P<0.05). Conclusions Transfection of HOXA13 in HKCs could inhibit the degree of EMT induced by albumin-overload, possibly by increasing BMP-7 expression.
关键词
白蛋白超载 /
上皮细胞-间充质转化 /
同源盒基因A13 /
骨形成蛋白-7 /
肾小管上皮细胞
Key words
Albumin overload /
Epithelial-mesenchymal transition /
HOXA13 /
Bone morphogenetic protein-7 /
Kidney tubular epithelial cell
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Eddy AA. Overview of the cellular and molecular basis of kidney fibrosis[J]. Kidney Int Suppl (2011), 2014, 4(1):2-8.
[2] Prunotto M, Budd DC, Gabbiani G, et al. Epithelialmesenchymal crosstalk alteration in kidney fibrosis[J]. J Pathol, 2012, 228(2):131-147.
[3] Wang Z, Zhao J, Zhang J, et al. Protective effect of BMP-7 against aristolochic acid-induced renal tubular epithelial cell injury[J]. Toxicol Lett, 2010, 198(3):348-357.
[4] Quinonez SC, Innis JW. Human HOX gene disorders[J]. Mol Genet Metab, 2014, 111(1):4-15.
[5] Wellik DM. HOX genes and kidney development[J]. Pediatr Nephrol, 2011, 26(9):1559-1565.
[6] Parker L, Mangwani J, Wakeling E, et al. Hallux valgus interphalangeus and a novel mutation in HOXA13. Part of the broadening spectrum of Hand-Foot-Genital syndrome[J]. Foot Ankle Surg, 2011, 17(2):e28-e30.
[7] Hamasaki Y, Doi K, Okamoto K, et al. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor simvastatin ameliorates renal fibrosis through HOXA13-USAG-1 pathway[J]. Lab Invest, 2012, 92(8):1161-1170.
[8] Williams TM, Williams ME, Heaton JH, et al. Group 13 HOX proteins interact with the MH2 domain of R-Smads and modulate Smad transcriptional activation functions independent of HOX DNA-binding capability[J]. Nucleic Acids Res, 2005, 33(14):4475-4484.
[9] Ibrini J, Fadel S, Chana RS, et al. Albumin-induced epithelial mesenchymal transformation[J]. Nephron Exp Nephrol, 2012, 120(3):e91-e102.
[10] 姜莹, 李晓燕, 何庆南, 等. 白蛋白超载对人肾小管上皮细胞EMT及激素耐药相关因素的影响[J]. 中国现代医学杂志, 2010, 20(21):3299-3308.
[11] Imagawa E, Kayserili H, Nishimura G, et al. Severe manifestations of hand-foot-genital syndrome associated with a novel HOXA13 mutation[J]. Am J Med Genet A, 2014, 164A(9):2398-2402.
[12] Li RX, Yiu WH, Tang SC. Role of bone morphogenetic protein-7 in renal fibrosis[J]. Front Physiol, 2015, 6:114.
[13] 李小琴, 郑玲芳. 新生儿呼吸窘迫综合征患儿血清TGF-β1及BMP-7的表达及意义[J]. 中国当代儿科杂志, 2015, 17(5): 445-448.
[14] Morgan EA, Nguyen SB, Scott V, et al. Loss of BMP7 and Fgf8 signaling in Hoxa13-mutant mice causes hypospadia[J]. Development, 2003, 130(14):3095-3109.
[15] Knosp WM, Scott V, Bachinger HP, et al. HOXA13 regulates the expression of bone morphogenetic proteins 2 and 7 to control distal limb morphogenesis[J]. Development, 2004, 131(18): 4581-4592.